|
WO2021001789A1
|
|
Therapeutic uses of oxidising hypotonic acid solutions
|
|
US2020197302A1
|
|
Ready to use diclofenac stick packs
|
|
US2020069624A1
|
|
Methods of normalizing amino acid metabolism
|
|
WO2018138690A1
|
|
Substantially sodium free diclofenac potassium oral solutions
|
|
JO3543B1
|
|
Modified release orally administered amino acid formulations
|
|
US2009186105A1
|
|
Device and composition for the delivery of a preservative-free balsamic cream
|
|
WO2007130507A2
|
|
Acute pain medications based on fast acting diclofenac-opioid combinations
|
|
WO2007127207A2
|
|
Fixed combination dosage forms for the treatment of migraine
|
|
US2007184106A1
|
|
Blister packaging for acute pain regimens
|
|
MXPA04006256A
|
|
Adhesive transdermal formulations of diclofenac sodium.
|
|
EP1312355A1
|
|
Water-soluble non-effervescent pharmaceutical compositions comprising non-steroidal anti-inflammatory drugs
|
|
EP1275377A1
|
|
Granulates containing liposoluble substances and process of preparation thereof
|
|
ITMI992202D0
|
|
New pharmaceutical compositions comprising anti-inflammatory components
|
|
EP0951905A2
|
|
Pharmaceutical compositions for programmed therapeutical coverage
|
|
EP0906092A1
|
|
Pharmaceutical compositions based on diclofenac
|
|
ITMI970468A1
|
|
A gel formulation, for topical use in the pharmaceutical, cosmetic, dietetic and veterinary industries
|
|
CH690814A5
|
|
Compositions for topical use containing sulphates polysaccharides.
|
|
CH690539A5
|
|
Dietetic composition comprises glyceryl phosphoryl ethanolamine
|
|
CA2224267A1
|
|
Solid pharmaceutical form for oral use
|
|
CH690295A5
|
|
Compositions for topical use based on thermal sludge.
|
